Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Equity Investor 12 February

Julia Lee
February 13, 2018

Weekly Wrap 9 February

Julia Lee
February 9, 2018

Equity Investor 5 February

Julia Lee
February 6, 2018

Market Update

Julia Lee
February 6, 2018

Market Update

Julia Lee
February 5, 2018

Weekly Wrap 2 February

Julia Lee
February 5, 2018

Market Update

Julia Lee
February 2, 2018

Market Update

Julia Lee
February 1, 2018

Market Update

Julia Lee
January 31, 2018

Market Update

Julia Lee
January 30, 2018

Equity Investor 29 Jan

Julia Lee
January 30, 2018

Reporting season preview

Julia Lee
January 29, 2018